FIELD: veterinary medicine; veterinary surgery.
SUBSTANCE: bio-glue based on an albumin solution and an aldehyde solution, as an active component, contains lyophilizate of fish skin mucus with specific weight of 0.19 g/cm3, dissolved in amount of 5% weight/volume in a 35% solution of bovine serum albumin and mixed with a 1.5% solution of glutaraldehyde in a ratio of protein solution/aldehyde solution from 50:1 to 25:1 by volume. Bio-glue based on the albumin solution and the aldehyde solution, as the active component, also contains lyophilizate of fish skin mucus with specific weight of 0.19 g/cm3, dissolved in amount of 5% weight/volume in a 25% solution of bovine serum albumin and mixed with a 3.0% solution of glutaraldehyde in a ratio of protein solution/aldehyde solution from 50:1 to 25:1 by volume. Bio-glue based on the albumin solution and the aldehyde solution, as the active component, also contains lyophilizate of fish skin mucus with specific weight of 0.19 g/cm3, dissolved in amount of 5% weight/volume in the 35% solution of bovine serum albumin and mixed with a 3.0% solution of glutaraldehyde in a ratio of protein solution/aldehyde solution from 50:1 to 25:1 by volume. Bio-glue based on the albumin solution and the aldehyde solution, as the active component, also contains lyophilizate of fish skin mucus with specific weight of 0.19 g/cm3, dissolved in amount of 5% weight/volume in the 25% solution of bovine serum albumin and mixed with a 1.5% solution of paraformaldehyde in a ratio of protein solution/aldehyde solution from 50:1 to 25:1 by volume. Bio-glue based on the albumin solution and the aldehyde solution, as the active component, also contains lyophilizate of fish skin mucus with specific weight of 0.19 g/cm3, dissolved in amount of 5% weight/volume in the 35% solution of bovine serum albumin and mixed with the 1.5% solution of paraformaldehyde in a ratio of protein solution/aldehyde solution from 50:1 to 25:1 by volume.
EFFECT: proposed bio-glue has high adhesive, fixing and hemostatic properties, which makes it suitable in veterinary surgery.
5 cl, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREPARING A PREPARATION BASED ON MAGNETIC NANOPARTICLES (MNCH) OF IRON OXIDE FOR MRT-DIAGNOSIS OF NEOPLASMS | 2017 |
|
RU2659949C1 |
| METHOD OF PREPARING AJMALINE CONJUGATE WITH BOVINE SERUM ALBUMIN | 1993 |
|
RU2088230C1 |
| PEPTIDE-IMMUNOGEN USED IN THERAPEUTIC VACCINE FOR METASTATIC BREAST CANCER TREATMENT | 2015 |
|
RU2624862C2 |
| METHOD OF INCREASING HEMOCOMPATIBILITY OF MEDICAL PRODUCTS | 2023 |
|
RU2808584C1 |
| PEPTIDE-IMMUNOGEN USED IN THERAPEUTIC VACCINE FOR TREATMENT OF METASTATIC BREAST CANCER OF CATS AND DOGS | 2015 |
|
RU2612015C2 |
| SORBENT FOR SEPARATION OF OPTICAL ISOMERS OF SUBSTANCES AND ANALYSIS THEREOF IN BIOLOGICAL FLUIDS BY HPLC AND PREPARATION METHOD THEREOF | 2014 |
|
RU2592893C2 |
| METHOD OF USING FISH SKIN MUCUS FOR ACTIVATION OF PLATELET AGGREGATION AND BLOOD CLOTTING IN VITRO | 2017 |
|
RU2652444C1 |
| WOUND BANDAGE INCLUDING PROTEIN POLYMER AND POLYFUNCTIONAL SPACER | 2005 |
|
RU2349347C2 |
| METHOD FOR MAKING BIOLOGICAL VENOUS-VALVE PROSTHESIS | 2010 |
|
RU2429023C1 |
| COMPOSITE PLAGUE ANTIGEN F1-DIAGNOSTICUM FOR INDICATION OF SPECIFIC ANTIBODIES | 2015 |
|
RU2582941C1 |
